Phase 2/3 Covaxin Trials Among 2-18-Year-Olds To Begin In 10-12 Days

The Phase II/III clinical trial of Covaxin in the 2-18-year-olds will begin in the next 10-12 days, senior NITI Aayog member VK Paul announced Tuesday.

The Phase II/III clinical trial of Covaxin, indigenous COVID-19 vaccine, in the 2-18-year-olds will begin in the next 10-12 days and has been approved by the Drugs Controller General Of India, senior NITI Aayog member VK Paul announced Tuesday.